What is NDC 61269-640?

61269-640 is the product NDC for ZYPREXA Intramuscular (olanzapine), Olanzapine 10 mg/2mL injection, powder, for solution, listed with the FDA by H2-Pharma LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

ZYPREXA Intramuscular (Olanzapine).

H2-Pharma LLC, NDC labeler code 61269. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for ZYPREXA Intramuscular?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

ZYPREXA Intramuscular NDC 61269-640

NDC codes

FDA NDC Directory

Product NDC (as listed)61269-640Labeler and product segments. Claims need a package NDC.

Product NDC at billing width61269-0640Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
61269-640-20	6126906402061269064020	1 VIAL in 1 CARTON (61269-640-20) / 2 mL in 1 VIALMarketed from Apr 1, 2004

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): ZYPREXA IntramuscularSuffix: Intramuscular
Generic name (nonproprietary): olanzapine
Active ingredients: Olanzapine — 10 mg/2mL
Dosage form: Injection, Powder, For solution
Route: Intramuscular
Labeler: H2-Pharma LLCNDC labeler code 61269
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 021253
Marketing start: Apr 1, 2004
Listing expires: Dec 31, 2027
Identifiers: Product ID 61269-640_b23e8030-2d91-4970-b001-c13e5c94204bSPL ID b23e8030-2d91-4970-b001-c13e5c94204b
Pharmacologic class: Atypical Antipsychotic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N461269064020 followed by a unit qualifier and the quantity

Package 61269-0640-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 61269-640

What is NDC 61269-640?: 61269-640 is the product NDC for ZYPREXA Intramuscular (olanzapine), Olanzapine 10 mg/2mL injection, powder, for solution, listed with the FDA by H2-Pharma LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: ZYPREXA Intramuscular (Olanzapine).
What is the active ingredient?: Olanzapine.
Who is the labeler?: H2-Pharma LLC, NDC labeler code 61269. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for ZYPREXA Intramuscular?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

ZYPREXA Intramuscular (Olanzapine) NDC 61269-640